Water Island Capital’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Water Island Capital’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,241,843	Closed	-$857K	–	144
2020 Q4	$857K	Buy	1,241,843 +1,231,843	+12,318%	+$2.62M	0.06%	80
2020 Q3	$23K	Buy	+10,000	New	+$28.6K	﹤0.01%	91
2020 Q1	–	Sell	-20,000	Closed	-$60K	–	72
2019 Q4	$60K	Buy	+20,000	New	+$52K	﹤0.01%	58

Other funds holding BMY.RT

JCI

Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return

TNB

Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return

WAM

Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Water Island Capital's BMY.RT Position: Q1 2021 in Review

Water Island Capital sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 1,241,843 shares — an estimated $857K sold.

Water Island Capital first reported a position in BMY.RT in Q4 2019 and held it in 3 quarters. The position peaked at $857K in Q4 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

Water Island Capital reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
Water Island Capital sold 1,241,843 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $857K.
Water Island Capital first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 3 quarters.
Water Island Capital's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $857K in Q4 2020.
12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Water Island Capital's 13F filing for Q1 2021, filed 13 May 2021.